(Q31967563)

5 July 2017

title

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer (English)

1 reference

5 July 2017

main subject

phase II clinical trial

0 references

1 reference

1 reference

Clark PE

1

1 reference

5 July 2017

Peereboom DM

2

1 reference

5 July 2017

Dreicer R

3

1 reference

5 July 2017

Levin HS

4

1 reference

5 July 2017

Clark SB

5

1 reference

5 July 2017

Klein EA

6

1 reference

5 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

57

1 reference

5 July 2017

issue

2

1 reference

5 July 2017

page(s)

281-285

1 reference

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Is "off-protocol" chemotherapy for androgen-independent carcinoma of prostate warranted?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Initial dissection of the lateral fascia reduces the positive margin rate in radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Contemporary results of anatomic radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy. A comparative study of radical prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2900914-6

7 January 2021

10.1016/S0090-4295(00)00914-6

Identifiers

DOI

1 reference

5 July 2017

1 reference